In times of the Corona Pandemic clinical trials are a challenge. What do we have to consider, what are the regulatory aspects? What advices do we get from the FDA and EMA? Find some answers given by Dr. Andreas Grund.

In times of the Corona Pandemic clinical trials are a challenge. What do we have to consider, what are the regulatory aspects? From the start-up phase of new clinical trials ,remote monitoring to close-out visits. Find some answers given by Dr. Andreas Grund.